Fred C. Kass, MD

Kass says the adjuvant setting has produced positive results, which has allowed he and his colleagues to effectively palliate metastatic patients better than ever before. However, optimal sequencing is still being determined.

Some metastatic malignancies can now be managed as chronic illnesses, says Kass. By being able to control these malignancies, Kass and his colleagues are now seeing recurrences of metastases to the central nervous system (CNS) as the limiting factor for quality and quantity of life.

Fred C. Kass, MD, oncology/hematology, internal medicine, Cancer Center of Santa Barbara, discusses HER2-positive breast cancer advancements.

Videos

Fred C. Kass, MD, oncology/hematology, internal medicine, Cancer Center of Santa Barbara, discusses HER2-positive breast cancer advancements.


Fred C. Kass, MD | Authors

Articles

Dr. Kass Discusses HER2-Positive Breast Cancer Advancements